Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2

The purpose of this study is to investigate a safe dose of TAK-165, once daily (QD), in patients with HER2-tumor expression.

本研究旨在考察TAK-165每日一次（QD）给药在人表皮生长因子受体2（HER2）阳性肿瘤患者中的安全剂量。